All News Vista Pharmaceuticals Limited

Equities

VISTAPH6

INE427C01021

Market Closed - Bombay S.E. Other stock markets 11:00:52 18/06/2024 BST			5-day change	1st Jan Change
13.51 ^INR	-2.81%		+1.96%	-7.91%

05-28	Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
02-10	Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-28	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-10	CI
Vista Pharmaceuticals Limited announced that it expects to receive INR 0.533334 million in funding	01-07	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-10	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	12/08/23	CI
Vista Pharmaceuticals Limited Announces the Resignation of Mr. Nishant Talreja from the Post of Company Secretary, Compliance Officer and Key Managerial Personnel	16/06/23	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	30/05/23	CI
Vista Pharmaceuticals Limited Announces Change in Corporate Office Address	10/04/23	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/02/23	CI
Vista Pharmaceuticals Limited announced that it has received INR 61.895 million in funding	13/12/22	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	15/11/22	CI
Vista Pharmaceuticals Appoints Chairman	20/10/22	MT
Vista Pharmaceuticals Limited Announces Executive Changes	14/10/22	CI
Vista Pharmaceuticals Limited Approves Resignation of Narendra Gilaka as Independent Director of the Company	08/09/22	CI
Vista Pharmaceuticals Limited announced that it expects to receive INR 66.895 million in funding	02/09/22	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/08/22	CI
Vista Pharmaceuticals Limited Announces Resignation of Akash Bhagadia as Company Secretary and Compliance Officer	27/06/22	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/05/22	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/05/22	CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/02/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Vista Pharmaceuticals Limited

Equities

VISTAPH6

INE427C01021

All News

Filters